Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hepatology
Link
https://link.springer.com/content/pdf/10.1007/s12072-020-10078-2.pdf
Reference16 articles.
1. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, et al. 7 on behalf of the AGA. AGA institute rapid review of the GI and liver manifestations of COVID-19, meta analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020. https://doi.org/10.1053/j.gastro.2020.05.001.
2. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, et al. COVID-19: abnormal liver function tests. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.04.006.
3. Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, Wu KH, et al. On behalf og Chinese Society of IBD. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5(5):425–7. https://doi.org/10.1016/S2468-1253(20)30076-5.
4. Gandhi RT, Lynch JB, Del Rio C. Mild or moderate covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMcp2009249.
5. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York city area. JAMA. 2020. https://doi.org/10.1001/jama.2020.6775.
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Liver pathology in COVID-19 after end of pandemic: Modern view of problem;Medical alphabet;2024-01-17
2. NAFLD and NASH are obesity‐independent risk factors in COVID‐19: Matched real‐world results from the large PINC AI™ Healthcare Database;Liver International;2023-12-18
3. Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate;Life;2023-12-11
4. The impact of the COVID‐19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan: A multicenter collaborative observational study;Hepatology Research;2023-12-08
5. Predictors of inpatient outcomes of COVID‐19 infection in patients with cirrhosis in the early pandemic phase: A nationwide survey;JGH Open;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3